| 标题 |
EXTEND II: an open-label phase III multicentre study to evaluate efficacy and safety of ranibizumab in Chinese patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration |
| 网址 | |
| DOI | |
| 其它 |
期刊:BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 作者:Zhao J; Li X; Tang S; Xu G; Xu X; et al 出版日期:2014/12/01 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)